Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-03-30 Purchase(A) | 2023-09-06 5:13 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 700,000 | $20 | $14,000,000 | 700,000 (Indirect) | View |
2023-08-29 Purchase | 2023-08-30 6:06 pm | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 12,000 | $2.3058 | $27,670 | 23,806 (Direct) | View |
2023-08-28 Purchase | 2023-08-30 6:02 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 2,235,000 | $2.4043 | $5,373,650 | 5,032,501 (Indirect) | View |
2022-12-19 Purchase | 2022-12-21 5:00 pm | Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO | 7,450 | $8.3897 | $62,503 | 132,619 (Direct) | View |
2022-12-16 Purchase | 2022-12-20 6:45 pm | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 900,000 | $8.4156 | $7,574,078 | 6,526,476 (Indirect) | View |
2022-12-16 Purchase | 2022-12-20 6:37 pm | Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 900,000 | $8.4156 | $7,574,078 | 6,526,476 (Direct) | View |
2022-12-09 Purchase | 2022-12-12 5:22 pm | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $7.9617 | $119,426 | 112,024 (Direct) | View |
2022-03-21 Purchase | 2022-03-22 7:28 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 25,000 | $18.99 | $474,680 | 6,047,629 (Indirect) | View |
2022-03-18 Sale | 2022-03-22 7:26 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director | 590,880 | $19.07 | $11,266,197 | 4,139,950 (Indirect) | View |
2021-08-31 Purchase | 2021-09-02 5:06 pm | Design Therapeutics Inc. | DSGN | William Arsani Director | 40,000 | $15.45 | $618,000 | 6,022,629 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-03-30 Conversion(A) | 2023-09-06 5:13 pm | N/A N/A | Design Therapeutics Inc. | DSGN | William Arsani Director | 2,032,501 | $0 | 700,000 (Indirect) | View |
2023-09-01 Option Award | 2023-09-05 5:33 pm | N/A 2033-08-31 | Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson | 2,100,000 | $0 | 2,100,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:48 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | Xu Stella Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | William Arsani Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | Berger Heather A. Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A 2033-05-30 | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $0 | 15,000 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 4:43 pm | N/A 2033-01-31 | Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer | 75,000 | $0 | 75,000 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 4:41 pm | N/A 2033-01-31 | Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer | 140,000 | $0 | 140,000 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 4:40 pm | N/A 2033-01-31 | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 415,000 | $0 | 415,000 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 4:39 pm | N/A 2033-01-31 | Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO | 415,000 | $0 | 415,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:17 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Xu Stella Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:16 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:10 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Schmid John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:08 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | William Arsani Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:07 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:06 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 5:05 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Berger Heather A. Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-03-16 Other | 2022-03-18 5:37 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 11,806 | $0 | 23,612 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 7:51 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer | 350,000 | $0 | 350,000 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 7:50 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 475,000 | $0 | 475,000 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 7:50 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO | 475,000 | $0 | 475,000 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 7:49 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer | 50,000 | $0 | 50,000 (Direct) | View |
2021-10-01 Option Award | 2021-10-04 4:53 pm | N/A 2031-09-30 | Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer | 135,000 | $0 | 135,000 (Direct) | View |
Ownership | 2021-08-17 7:21 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Giangiulio Dawn Principal Accounting Officer | 0 | $0 | 44,308 (Direct) | View |
2021-06-15 Option Award | 2021-06-16 5:21 pm | N/A 2031-06-14 | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-06-16 5:20 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Prasad Deepa Director | 0 | $0 | 1,817,273 (Indirect) | View |
2021-06-15 Option Award | 2021-06-16 5:17 pm | N/A 2031-06-14 | Design Therapeutics Inc. | DSGN | Behanna Heather Director | 30,000 | $0 | 30,000 (Direct) | View |